PRISM BioLab Co.,LTD
Status: Publicly traded
Last reviewed: October 2026
Direct answer
PRISM BioLab Co.,LTD is publicly traded on JPX under the ticker 206A.T.
PRISM BioLab Co., LTD. engages in the research and development of pharmaceuticals using its proprietary drug discovery platform, PepMetics Technology. The company's technology focuses on creating peptide mimetic small molecules designed to mimic α-helix or β-turn peptides, which are essential for protein-protein interactions. Through its platform, PRISM aims to discover drugs for what were previously considered...
Can you invest in PRISM BioLab Co.,LTD?
Yes. PRISM BioLab Co.,LTD is publicly traded on JPX under the ticker 206A.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for PRISM BioLab Co.,LTD
Detailed equity research is provided by MarketSnap.